Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

PREVIEW · PREVention of diabetes through lifestyle Intervention and population studies in Europe and around the World

FP7Status: CLOSED1 January 201331 December 2018EU funding €8,993,475

The primary goal of PREVIEW is to identify the most efficient lifestyle pattern for the prevention of type-2 diabetes in a population of pre-diabetic overweight or obese individuals. The project comprises two distinct lines of evidence, both embracing European and overseas countries:1) A multicentre, clinical randomized intervention trial with a total of 2,500 pre-diabetic participants, including children and adolescents, adults and elderly. The duration will be 3 years for the adults and elderly, and 2 years for the children and adolescents.2) Large population studies using data from all age groups.Focus in both lines of evidence will be on diet (specifically protein and glycemic index) and intensity of physical activity, as well as their interaction with the lifestyle factors, habitual stress and sleeping pattern as well as behavioural, environmental, cultural, and socioeconomic variables.PREVIEW will significantly increase our knowledge on how specific lifestyle factors can help preventing type-2 diabetes. Type-2 diabetes accounts for about 90% of all cases of diabetes, primarily caused by the worldwide obesity epidemic. Diabetes is a costly disease and according to WHO, the direct health care costs of diabetes range from 2.5% to 15% of annual national health care budgets. This worrying trend calls for action and a need for a variety of innovative approaches. PREVIEW aims to be such an innovative attempt including all necessary disciplines and stakeholders, who can contribute to developing new ways for the prevention of this wide-spread life-style related disease.The strategic impact of PREVIEW concerns the massive problems associated with the global diabesity epidemic (obesity and type-2 diabetes) and therefore includes partners from Europe (East, West, North and South) and Australia, New Zealand, and Canada. PREVIEW will thereby contribute to improving health over the life-span of the population in Europe as well as worldwide. Overall the public health and socio-economic impact of PREVIEW is expected to be very significant.

Consortium · 15 organisations

coordinator

KOBENHAVNS UNIVERSITET

DK · €2,336,808

participant

NETUNION SARL

CH · €271,415

participant

MEDICAL UNIVERSITY SOFIA

BG · €633,680

participant

SWANSEA UNIVERSITY

UK · €315,000

participant

HELSINGIN YLIOPISTO

FI · €793,754

participant

UNIVERSITEIT MAASTRICHT

NL · €987,590

participant

MEYERS MADHUS AS

DK · €140,950

participant

TERVEYDEN JA HYVINVOINNIN LAITOS

FI · €430,982

participant

THE UNIVERSITY OF SYDNEY

AU

participant

UNIVERSIDAD DE NAVARRA

ES · €778,268

participant

THE UNIVERSITY OF AUCKLAND

NZ

participant

THE UNIVERSITY OF NOTTINGHAM

UK · €1,086,555

participant

WAGENINGEN UNIVERSITY

NL · €733,476

participant

UNIVERSITY OF STUTTGART

DE · €484,998

participant

UNIVERSITE LAVAL

CA

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.